5th Computational Drug Discovery & Development (CDD) for Biologics Summit

With improved computational tools and increasing data availability, computational drug design and development for biologics is becoming a reality, enabling scientists to convert actionable insights from biophysical and structural data into breakthrough biotherapeutics. For drug developers now is the time to harness this computing power to identify and to advance biologics candidates of superior affinity, stability and efficacy.

CDD for Biologics has been specifically designed to help biopharmaceutical companies define strategies to further adapt these tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines.

Join a diverse faculty of experts this October for the 5th annual gathering to uncover progress made, and how we can accelerate the adoption of computational tools in the discovery and development of biologics.

Hear What Our Attendees Say

“It’s a great conference in the sense that we take home not only new methods and models, but more importantly the design and thinking process behind them” – Yao Fan, Boehringer Ingelheim

“I’m impressed by how much I learnt by attending the conference. It’s a great opportunity to learn the key issues facing the industry and various strategies to address them. It was very rewarding” - Liwei Li, EMD Serono

Partners:

Schrodinger Company Logo

Attending Companies:

Biogen Company Logo
Genentech Company Logo
Sanofi Company Logo
EMD Serono Company Logo
Bristol-Myers Squibb Company Logo
Merck Company Logo
Kadmon Company Logo
Just Biotherapeutics Company Logo